These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7336421)

  • 1. Inhibition of responder cell activity in mixed leukocyte culture reactions. I. Evidence of cross-reactivity of B7-antibody with HLA-B8.
    de Rooij-Doyer E; Bruning JW; van Rood JJ
    Tissue Antigens; 1981 Sep; 18(3):154-65. PubMed ID: 7336421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of responder cell activity in mixed leukocyte culture reactions. II. Influence of antibody binding and shedding properties within a B7-cross-reactivity group.
    de Rooij-Doyer E; Schoen MA; Bruning JW; van Rood JJ
    Tissue Antigens; 1981 Oct; 18(4):205-16. PubMed ID: 6178176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HC restricted dual specific inhibition of mixed leukocyte culture reactions by human HLA antibody molecules.
    de Rooij-Doyer E; Jonker M; Bruning JW; van Rood JJ
    Tissue Antigens; 1980 Jan; 15(1):47-59. PubMed ID: 12735332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA antigens: rabbit antisera reacting with all A series or all B series specificities.
    Cresswell P; Ayres JL
    Eur J Immunol; 1976 Feb; 6(2):82-8. PubMed ID: 786698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HLA-B12 and -B40 cross-reactive groups and their serological relationships.
    Darke C
    Tissue Antigens; 1983 Apr; 21(4):281-95. PubMed ID: 6190263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The binding of monoclonal antibodies to cell surface molecules. Quantitative analysis of the reactions and cross-reactions of an antibody (MB40.3) with four HLA-B molecules.
    Parham P
    J Biol Chem; 1984 Nov; 259(21):13077-83. PubMed ID: 6333424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible mechanisms by which alloantisera inhibit in the MLC test.
    Jonker M; de Rooy-Doyer L
    Tissue Antigens; 1980 Jan; 15(1):1-10. PubMed ID: 12735326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
    Yannelli JR; Moore LC; Engelhard VH
    J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
    Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies against two separate alloantigenic sites of HLA-B40.
    Parham P
    Immunogenetics; 1981; 13(6):509-27. PubMed ID: 7026428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic determinants of the HLA-B7 molecule; Bw6- and B7-specific determinants are spatially separate.
    Parham P
    Immunogenetics; 1983; 18(1):1-16. PubMed ID: 6190743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of an HLA-Bw6-related specificity by the HLA-Cw3 molecule.
    Layet C; Delovitch T; Ferrier P; Caillol DH; Jordan BR; Lemonnier FA
    Immunogenetics; 1985; 21(5):469-78. PubMed ID: 2581891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One allogeneic cytolytic T lymphocyte clone distinguishes three different HLA-B27 subtypes: identification of amino acid residues influencing the specificity and avidity of recognition.
    Aparicio P; Vega MA; López de Castro JA
    J Immunol; 1985 Nov; 135(5):3074-81. PubMed ID: 2413111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of cell-mediated lympholysis (CML) in man.
    Singal DP; Wadia YJ
    Tissue Antigens; 1980 Feb; 15(2):177-88. PubMed ID: 12735318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of HLA-Bw73 by serology and one-dimensional isoelectric focusing patterns.
    Eynon EE; Yang SY; Cronin CR; Alosco SM; Alper CA; Yunis EJ
    Hum Immunol; 1986 Aug; 16(4):356-63. PubMed ID: 2428782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reanalysis of the HLA-B7 cross-reactive group.
    Darke C
    Tissue Antigens; 1983 Nov; 22(5):326-34. PubMed ID: 6606863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of MLC stimulator function by antibodies directed to non-HLA antigens.
    Jonker M
    J Immunogenet; 1979 Dec; 6(6):419-27. PubMed ID: 160436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of nonclassical Fc receptor-associated, Ag-B antigens (Ia) in rat allograft enhancement.
    Soulillou JP; Carpenter CB; d'Apice AJ; Strom TB
    J Exp Med; 1976 Feb; 143(2):405-21. PubMed ID: 129499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of anti-HLA-B27 cytotoxic T lymphocytes.
    Breuning MH; Breur BS; Engelsma MY; Huis B; Iványi P
    Tissue Antigens; 1983 Oct; 22(4):267-82. PubMed ID: 6606238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.